Navigation Links
Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Date:8/19/2007

ly well tolerated by the study participants with side effects consistent with those in the currently approved label. The company plans to present the data at a major medical meeting in the future.

About Breakthrough Pain

Breakthrough pain is a component of chronic pain that is characterized by its rapid onset, moderate to severe intensity, and relatively short duration. Breakthrough pain has an average onset of three to five minutes and typically lasts 30 to 60 minutes.

About FENTORA

FENTORA is indicated only for the management of breakthrough pain in patients with cancer who are already receiving and who are tolerant to opioid therapy, as described below in the FENTORA label, for their underlying persistent cancer pain. FENTORA incorporates a drug delivery system that generates transient changes in pH, which may optimize how well the tablet dissolves and how quickly the medicine passes across the lining of the cheek, or buccal mucosa. Serious adverse events associated with all opioids are respiratory depression (potentially leading to apnea or respiratory arrest), circulatory depression, hypotension, and shock. All patients should be followed for symptoms of respiratory depression. The most common (greater than or equal to 10 percent) adverse events observed in FENTORA cancer clinical trials were nausea, dizziness, vomiting, fatigue, headache, constipation, anemia, somnolence, and peripheral edema. Most adverse events were mild to moderate in severity. No attempt was made to correct for concomitant use of around-the-clock opioids or cancer-related symptoms. In addition, application site reactions were reported in nine percent of patients, tended to occur early on treatment, and resulted in treatment discontinuation in only two percent of patients. PHYSICIANS AND OTHER HEALTHCARE PROVIDERS MUST BECOME FAMILIAR WITH THE

IMPORTANT WARNINGS IN THIS LABEL.

FENTORA contains fentanyl, an opioid agonist and a Schedul
'/>"/>

SOURCE Cephalon, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5

Related medicine technology :

1. Cephalon Presents Positive Results for Fentora in Breakthrough Pain Associated with Neuropathic Conditions
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... FREMONT, Calif. , July 7, 2015  The ... and Velos, Inc. have entered into a seven year ... research nationally throughout South Korea and ... signing was accompanied by a two day joint workshop between ... Korea.  National Cancer Center President Dr. Lee ...
(Date:7/7/2015)... , Kalifornien, 7. Juli 2015 /PRNewswire/ ... Medizintechnikunternehmen, das sich der Entwicklung innovativer Geräte ... heute den Zugang von R. Michael ... Herr Kleine verfügt über eine ... Medizintechnik und Gesundheitsfürsorge. Er hat verschiedene globale ...
(Date:7/7/2015)... Md. , July 7, 2015 ... (CRO) focusing in Oncology, Vaccines, and General Medicine ... the final locked database to Heron Therapeutics, Inc. ... 3 receptor antagonist product candidate SUSTOL® (granisetron ... regimen with the IV NK 1 receptor ...
Breaking Medicine Technology:National Cancer Center of South Korea and Velos Sign Long-Term Velos eResearch Agreement 2National Cancer Center of South Korea and Velos Sign Long-Term Velos eResearch Agreement 3Sequent Medical beruft Mike Kleine in den Aufsichtsrat 2Sequent Medical beruft Mike Kleine in den Aufsichtsrat 3Accelovance Completes Trial Enrollment and Delivery of Clinical Data for Heron Therapeutics' Phase 3 Trial 2
... ALTO, Calif., Jan. 10, 2012 Varian Medical Systems (NYSE: ... a new radiotherapy treatment planning tool designed to work with ... the amount of time needed for planning advanced treatments. ... clinician must take the patient,s anatomical images and identify and ...
... Agreement allows development for potential treatment of chronic constipation ... SHPGY ), the global specialty biopharmaceutical company, announced today ... market Resolor ® (prucalopride) in the United States ... of the agreement have not been disclosed. ...
Cached Medicine Technology:Varian Medical Systems Receives FDA 510(k) Clearance for Software that Speeds Up Radiotherapy Treatment Planning 2Shire Acquires US Rights to Resolor(R) (prucalopride) 2Shire Acquires US Rights to Resolor(R) (prucalopride) 3Shire Acquires US Rights to Resolor(R) (prucalopride) 4
(Date:7/8/2015)... ... July 08, 2015 , ... Health & Disability ... on July 29th in Bettendorf, IA. This workshop will be presented to community-based ... members, veterans, and their families. Professionals from both civilian and military organizations are ...
(Date:7/8/2015)... (PRWEB) , ... July 08, 2015 , ... Garden ... offering the finest full body massage in NYC. The attractive masseuses that staff Garden ... atmosphere for customers to relax and unwind. With plenty of parking, and a location ...
(Date:7/7/2015)... ... July 08, 2015 , ... The National Association of ... its VIP Woman of the Year Circle. She is recognized with this prestigious distinction ... women, boasting more than 700,000 members and over 200 operating Local Chapters. , “I’m ...
(Date:7/7/2015)... ... July 07, 2015 , ... World Patent ... Tube Holder, a medical invention that prevents IV lines from getting entangled. ... which will be worth $133 billion by 2016," says Scott Cooper, CEO and ...
(Date:7/7/2015)... ... 07, 2015 , ... Researchers at UC Davis have reviewed ... didn’t) and how similar programs can be improved. , Interviewing staff, clinicians and ... of Practice (HEALTH COP) program, the team identified four factors that helped clinicians ...
Breaking Medicine News(10 mins):Health News:Health & Disability Advocates to Host Military Sexual Trauma Workshop for Behavioral Health Practitioners and Victim Advocates 2Health News:Garden Retreat Spa Celebrates 8 Years Serving NYC 2Health News:National Association of Professional Women Inducts Dr. Alyssa Greedy, Pharm. D., Pharmacy Manager at Walgreens, Into its VIP Woman of the Year Circle 2Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 2Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 3Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 4Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 5Health News:UC Davis Study Identifies Tools, Strategies for Enhancing Obesity Prevention in Rural Communities 2Health News:UC Davis Study Identifies Tools, Strategies for Enhancing Obesity Prevention in Rural Communities 3
... to improve the quality and safety of health ... Patient Safety Organizations,(PSOs) was announced today by the ... PSOs are private entities recognized by the Secretary ... health care providers. They are,new and separate from ...
... Medicine, by Maria Siemionow, ... M.D., ... for a moment, being unable to touch the face of someone you,love. "Now ... Maria Siemionow, section head of plastic,surgery research at Cleveland Clinic ( http://www.clevelandclinic.org/ ), ...
... the University of North Carolina at Chapel Hill shows for ... to function at the cell surface also functions at a ... for drug development as they involve G protein-coupled receptors (GPCRs). ... of modern medicinal drugs, such as antihistamines and drugs for ...
... The Chicago Tribune has published a,feature story on ... the,problem, implications for loving dog owners, and treatments and ... link at end of release.,Morris Animal Foundation (MAF) is ... in the next 10 to 20 years. MAF can ...
... of Sheffield and STFC Rutherford-Appleton Laboratories have developed one ... heart of future medical scanners. The new technology will ... of the human body at a lower-cost to the ... developed as part of the 4.5m Basic Technology MI-3 ...
... new services to energy workers, WASHINGTON, Feb. ... enhanced services to assist nuclear weapons industry,workers with ... department,s resource centers will now work one-on-one,with claimants ... under the Energy Employees Occupational Illness Compensation,Program Act ...
Cached Medicine News:Health News:New Patient Safety Proposed Regulation Aims to Improve Health Care Quality and Patient Safety 2Health News:New Patient Safety Proposed Regulation Aims to Improve Health Care Quality and Patient Safety 3Health News:New Patient Safety Proposed Regulation Aims to Improve Health Care Quality and Patient Safety 4Health News:Cleveland Clinic Press Releases Book About a Surgeon's Mission to Perform the World's First Full Face Transplant 2Health News:Discovery of 'overdrive' protein could broaden drug design options 2Health News:U.S. Labor Department Increases Claim Assistance for Energy Workers 2
... manifold allows processing of up to 24 spin columns ... spin columns into and out of a centrifuge. ... Time savings rapid vacuum-driven purification and cleanup ... Convenience minimal hands-on-time ...
... automated alternative to Kuderna-Danish, Rotary, Vacuum-Style and Nitrogen Blow-Down Evaporators. For over ten years TurboVap concentration technology ... ... ... ...
... BioVacTM96 Vacuum Manifold system has been designed ... extraction kits. The kit can handle 96 ... simultaneously for effective extraction and purification. While ... a spin column, the BioVac 96 Vacuum ...
The Empore 96 well plate vacuum manifold comes complete with waste tray, gasket and shims, may be used as a stand-alone or with 96-well automation....
Medicine Products: